[Obesity: one of this century's greatest health challenge?].
The prevalence of overweight and obesity exceed 50% in many European countries. Obesity is responsible for 2-8% of all health costs and 10-13% of all deaths in Europe. Only a fraction of patients obtain a medically relevant weight loss of 5-10% through lifestyle intervention. Surgery is limited to severe obesity and is very costly; therefore pharmaceuticals are a relevant alternative. Such treatment is hampered by the lack of official guidelines and a relatively limited effect compared to the expectations of patients as well as medical staff. Guidelines and official subsidies are debated.
Toubro
Søren
S
Københavns Universitet, Det Biomedicinske Fakultet, Institut for Human Ernaering, og Reduce - en forskningsklinik, og Gentofte Hospital, Klinisk Ernaeringsenhed, Denmark. st@reduce.dk
Astrup
Arne V
AV
D000328:Adult; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D050110:Bariatric Surgery; D003718:Denmark / Q000453:epidemiology; D005060:Europe / Q000453:epidemiology; D005260:Female; D014943:Global Health; D017048:Health Care Costs; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000401:mortality / Q000517:prevention & control* / Q000628:therapy; D015995:Prevalence; D011634:Public Health; D015431:Weight Loss
D019440:Anti-Obesity Agents